Thailand is a large population country in Southeast Asia with strong market demand for medical devices. The Thai FDA (TFDA) classifies devices into 4 risk classes (Class 1–4). The maximum review period for Class 4 high-risk devices can reach 300 working days. Besides full review and abridged review, there is a unique Reliance fast-track route that accepts approvals from Singapore HSA. This open class at Beijing CMEF breaks down the full registration workflow for high-risk medical devices in Thailand and sorts out key pitfalls to avoid.
Thailand’s medical device regulator is the Thai FDA (TFDA), governed by the Medical Device Act B.E. 2551 (2008) as amended in 2019.
Note: If the primary mechanism of action of a product is pharmacological, immunological or metabolic, it will be classified as a pharmaceutical product and does not fall under medical device regulations.
| Class | Risk Level | Regulatory Route | Key Notes |
|---|---|---|---|
| Class 1 | Low Risk | Listing | Document checklist only; no expert review |
| Class 2 | Low-to-Medium Risk | Notification | Expert review required |
| Class 3 | Medium-to-High Risk | Notification | Expert review with deeper scrutiny than Class 2 |
| Class 4 | High Risk | License | Mandatory expert review; maximum review period of 300 working days |
Policy updated in 2022: Covers all Singapore HSA Class B/C/D devices.
Mechanism: Thailand unilaterally recognises Singapore HSA registration outcomes, waives expert review, shortening the timeline by 1–3 months.
Important reminder: Singapore does NOT recognise Thai approvals under this scheme; Singapore registration remains an independent review.
Mandatory conditions: The CSDT dossier submitted in Thailand must be identical to the Singapore registration package, accompanied by a signed consent letter from the Singapore registration holder. Home-use devices still require full Thai-language labelling and IFU.
Additional documents for Abridged Route: Manufacturer indication statement, market history statement, no-adverse-event statement, overseas approval certificate
ISO 13485 certificate is mandatory; applications will be rejected outright if missing.
| Risk Class | Reference Review Timeline |
|---|---|
| Class 1 | 30–60 working days, Listing |
| Class 2 / 3 | ~150 working days; Abridged route is 2–3 months faster |
| Class 4 | ~200 working days, capped at 300 working days |